Haukoos Jason S, White Douglas A E, Rowan Sarah E, Lyle Carolynn, Gravitz Stephanie, Basham Kellie, Godoy Ashley, Kamis Kevin, Hopkins Emily, Anderson Erik
Department of Emergency Medicine, Denver Health Medical Center, Denver, Colorado, USA.
Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
AIDS Patient Care STDS. 2021 Jun;35(6):211-219. doi: 10.1089/apc.2021.0012.
Our objective was to estimate the prevalence of pre-exposure prophylaxis (PrEP) eligibility, characterize self-perceived and quantified human immunodeficiency virus (HIV) risk, and assess PrEP knowledge and receptiveness of initiating PrEP among emergency department (ED) patients. We performed an IRB-approved cross-sectional study from two urban EDs. Patients were eligible if ≥18 years of age and not known to have HIV. Research staff obtained verbal consent and used a structured 29-item instrument to assess HIV risk, PrEP eligibility based on 2017 Centers for Disease Control and Prevention (CDC) guidelines, and general PrEP knowledge among unselected and enriched patient samples, the latter informed by the Denver HIV Risk Score (DHRS). We enrolled 1002 patients with a median age of 39 years; 54.8% were male, 30.9% White/non-Hispanic, 29.5% Black/non-Hispanic, and 22.5% Hispanic. In the full cohort, 119 [11.9%, 95% confidence interval (CI): 9.9-14.0%] were PrEP eligible, and among the unselected cohort, 36 (7.1%, 95% CI: 5.1-9.8%) were PrEP eligible. Using the DHRS, 100 patients were considered "high risk" with 32 (32.0%) reporting zero perceived risk. Correlation between the DHRS and self-perceived HIV risk was low ( = 0.13). Of the full cohort, 203 (20.3%) had heard of PrEP, and of these, 33 (16.3%) were PrEP eligible with 25 (75.8%) willing to start PrEP immediately. Yet, of the 119 patients who were PrEP eligible, only 34 (28.6%) had heard of PrEP. In summary, among a heterogeneous ED population, there was discordance in self-perceived and quantified HIV risk. HIV PrEP eligibility was ∼7% with the highest eligibility among those identified as DHRS "high risk." A significant opportunity exists to identify and initiate PrEP among ED patients.
我们的目标是估计暴露前预防(PrEP)的适用率,描述自我感知和量化的人类免疫缺陷病毒(HIV)风险,并评估急诊科(ED)患者中PrEP的知识以及开始PrEP的接受程度。我们在两家城市急诊科开展了一项经机构审查委员会(IRB)批准的横断面研究。年龄≥18岁且未知感染HIV的患者符合条件。研究人员获得了口头同意,并使用一份包含29个条目的结构化问卷来评估HIV风险、根据2017年疾病控制与预防中心(CDC)指南确定的PrEP适用情况,以及在未筛选和富集的患者样本中的一般PrEP知识,后者由丹佛HIV风险评分(DHRS)提供信息。我们纳入了1002名患者,中位年龄为39岁;54.8%为男性,30.9%为白人/非西班牙裔,29.5%为黑人/非西班牙裔,22.5%为西班牙裔。在整个队列中,119人[11.9%,95%置信区间(CI):9.9 - 14.0%]符合PrEP适用条件,在未筛选队列中,36人(7.1%,95%CI:5.1 - 9.8%)符合PrEP适用条件。使用DHRS,100名患者被认为“高危”,其中32人(32.0%)报告自我感知风险为零。DHRS与自我感知的HIV风险之间的相关性较低(r = 0.13)。在整个队列中,203人(20.3%)听说过PrEP,其中33人(16.3%)符合PrEP适用条件,25人(75.8%)愿意立即开始PrEP。然而,在1
19名符合PrEP适用条件的患者中,只有34人(28.6%)听说过PrEP。总之,在异质性的急诊科人群中,自我感知和量化的HIV风险存在不一致。HIV PrEP适用率约为7%,在被确定为DHRS“高危”的人群中适用率最高。在急诊科患者中识别并启动PrEP存在重大机会。